SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: biowa who wrote (6639)5/7/1999 10:51:00 AM
From: Biomaven  Read Replies (1) | Respond to of 9719
 
biowa,

at least one pdt (norcisapride) I've heard unimpressive reviews

Norcisapride was claimed to have two advantages - the first that it avoided cisapride's nasty drug interactions, the second that its efficacy was better and its indications were broader.

Can you tell us more about what you heard?

Peter